1. Home
  2. PLX vs NEN Comparison

PLX vs NEN Comparison

Compare PLX & NEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Protalix BioTherapeutics Inc. (DE)

PLX

Protalix BioTherapeutics Inc. (DE)

N/A

Current Price

$2.67

Market Cap

182.9M

Sector

Health Care

ML Signal

N/A

Logo New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

NEN

New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

N/A

Current Price

$57.00

Market Cap

197.0M

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
PLX
NEN
Founded
1993
1977
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Building operators
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
182.9M
197.0M
IPO Year
1996
1995

Fundamental Metrics

Financial Performance
Metric
PLX
NEN
Price
$2.67
$57.00
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$12.00
N/A
AVG Volume (30 Days)
757.1K
1.2K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
2.71%
EPS Growth
N/A
N/A
EPS
0.27
N/A
Revenue
$52,744,000.00
$89,196,544.00
Revenue This Year
$36.81
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$9.69
$19.68
Revenue Growth
N/A
10.76
52 Week Low
$1.53
$52.08
52 Week High
$3.19
$73.50

Technical Indicators

Market Signals
Indicator
PLX
NEN
Relative Strength Index (RSI) 62.68 40.42
Support Level $2.59 $52.08
Resistance Level $2.71 $66.30
Average True Range (ATR) 0.09 1.14
MACD 0.02 0.03
Stochastic Oscillator 87.78 39.18

Price Performance

Historical Comparison
PLX
NEN

About PLX Protalix BioTherapeutics Inc. (DE)

Protalix BioTherapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, production, and commercialization of therapeutics for rare diseases with important unmet needs. ProCellEx, a proprietary plant cell-based protein expression system, represents a new method for developing recombinant proteins in an industrial-scale manner. corporate includes the development of treatments for rare and orphan diseases. The Company operates as a single operating segment in Israel.

About NEN New England Realty Associates Limited Partnership Depositary Receipts Evidencing Units of Limited Partnership

New England Realty Associates LP is engaged in the business of acquiring, developing, holding for investment, operating, and selling real estate. The Partnership owns and operates various residential apartments, condominium units, and commercial properties located in Massachusetts and New Hampshire. The company generates revenue from rental income from residential and commercial properties recognized over the term of the related lease. The long-term goals of the Partnership are to manage, rent, and improve its properties and to acquire additional properties with income and capital appreciation potential as suitable opportunities arise.

Share on Social Networks: